• Introduction to In Vitro Pharmacology (IVP) and problematics faced during submission of IVP data for an IND application
  • How to pave the way to the FAIRification of IVP data? Two key steps:
    • Standardised data structure for submission of results – IVP module/GSRS
    • Repository of safety and secondary in vitro pharmacology assays: using a single, centralised protocol repository with an integrated ontology and providing a unique Identifier for each assay

  • Q&A session


  • Kevin Snyder (FDA)
  • Larry Callahan (FDA)
  • Jane Lomax (Scibite)
  • Chris Butler (Abbvie)


Fill in the form below to view a recording of the event